About CluePoints
AI-Powered Risk-Based Quality Management (RBQM) & Data Quality Oversight Solutions
- Industry
- Software Development
- Company size
- 201-500 employees
- Headquarters
- Avenue Albert Einstein 2A, Louvain-La-Neuve
- Founded
- 2012
- Company type
- Privately Held
CluePoints is the premier provider of RBQM and data quality oversight software. We’re leveraging the potential of AI using advanced statistics and ML to determine the quality, accuracy, and integrity of clinical trial data both during and after the study. Aligned with guidance from the FDA, EMA, ICH, and MHRA, CluePoints supports central and on-site monitoring, medical review, and quality risk management to drive a holistic risk-based strategy.
Coupled with thought leadership and consulting expertise to aid risk assessment and solution implementation, the result is positive clinical development outcomes, increased operational efficiency, lower costs, and reduced regulatory submission risk as part of the industry paradigm shift to RBQM.
To learn more about CluePoints, visit CluePoints.com.
Specialties
- Central Statistical Monitoring
- Risk-Based Monitoring solutions
- risk-based quality management
- and ICH E6 (R2)
Company locations
New Tech Centre, Avenue Albert Einstein 2A, Louvain-La-Neuve 1348, BE
1000 Continental Dr, Suite 240, King of Prussia, Pennsylvania 19406, US
Locations listed on the company profile. These may include offices outside the United States, and not every location is hiring.
Business areas
- Information Technology
- Risk Management
- Software
- Information Services
On LinkedIn
- Followers
- 15,503
- People linked to this company
- 311
People who list this company on LinkedIn, not a verified employee count. Figures reflect the saved company profile.
Funding raised
6,591,190 USD
Total reported by Crunchbase, in US dollars. This is funding raised, not company revenue or valuation.
Explore the company
Employer category
Other employer
Estimated from the company profile. This category has not been confirmed by the employer.